This is a working overview of solid-phase synthesis, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-12. Anything still debated is marked as such rather than presented as settled.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide, 28 residues | N-terminal fragment of prothymosin alpha |
| Molecular mass | About 3108 Da | Acetylated form |
| Isoelectric point | Near 4.2 | Acidic peptide |
| Appearance | White to off-white lyophilized powder | Common supplied form |
| Typical storage | -20 °C or below, dry | Solution stability is lower |
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Identity and purity are assessed with a small set of standard peptide methods. Reversed-phase high-performance liquid chromatography separates the main peak from truncated or oxidized species, and its area percentage is the usual purity measure. Mass spectrometry confirms the observed molecular mass against the expected value, while amino acid analysis or peptide mapping checks composition and sequence. Specifications for research-grade material are often stated as 95 percent or higher, though the exact limit depends on the supplier and the intended use.
Laboratory supplies of the peptide usually arrive as a lyophilized powder in sealed vials. The powder is hygroscopic, so a vial should be allowed to reach room temperature before it is opened to prevent condensation on the contents. Weighing and transfer are best performed in a low-humidity environment with clean tools. Once dissolved, the solution should be mixed gently rather than vortexed, because foaming and shear can reduce recovery of the peptide.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Practical handling focuses on limiting adsorption and contamination. The peptide dissolves readily in water, and dilute solutions tend to adhere to plastic and glass surfaces, so an inert carrier protein or a defined buffer can reduce losses in laboratory work. Workers also record the counter-ion form, since an acetate or trifluoroacetate salt changes the mass balance of the weighed powder. Documentation of lot number, purity value, and storage history supports reproducibility when results from different laboratories are compared.
Lyophilized material is generally held at reduced temperature to slow degradation, and storage at minus twenty degrees Celsius or lower is common practice for long-term retention. Short-term working portions are often kept between two and eight degrees Celsius. Once dissolved, the peptide is less stable than the dry powder, and repeated freeze-thaw cycles are associated with loss of material and with aggregate formation. Vials are usually allowed to reach room temperature before opening so that condensation does not introduce moisture, and solutions are protected from light where practical.
21 July – A study provides evidence for elements of the theory of 'Bullshit Jobs', which was formalized and popularized in 2018, showing that many workers consider their jobs of contemporary economics as objectively useless to society. 24 July The first detection of water in the terrestrial region of a disk already known to host two or more protoplanets is announced. The discovery, in a young system called PDS 70, is based on data from the James Webb Space Telescope. A study reports a 226% improvement in a memory test of healthy older adults (60–85) from overnight odorant diffuser use for 6 months. The olfactory sense is known to be linked to memory, but its stimulation was previously not trialed where application occurs during sleep. 25 July – A controversial study finds that a collapse of the Atlantic meridional overturning circulation (AMOC) is highly likely this century, and may occur as early as 2025. The 95% confidence interval is between 2025 and 2095. 26 July – DARPA, in collaboration with NASA, begins work on the first in-orbit demonstration of a nuclear thermal rocket engine. 27 July – The longest known cryptobiosis in a nematode is reported, with an organism revived after 46,000 years in Siberian permafrost. 28 July – A phylogenetic study proposes a hybrid of the farming and steppe hypotheses for the origin of Indo-European languages, contradicting elements of both. Hazard research is published: news outlets start reporting on a study from June finding high levels of PFAS in half of U.S.
The climate of Ghana is tropical, and there is wet season and dry season. Ghana sits at the intersection of three hydro-climatic zones. The eastern coastal belt is warm and comparatively dry, the south-west corner of Ghana is hot and humid, and the north of Ghana is hot and dry. Climate change in Ghana has impacts on the people of Ghana. Increasing temperatures and changes in rainfall, extreme weather, drought, wild fires, floods and sea-level rise are expected to negatively affect the country's infrastructure, hydropower production, food security, water supply, and coastal and agricultural livelihoods such as farming and fisheries. Ghana's economy will be impacted by climate change, due to its dependence on climate-sensitive sectors such as agriculture, energy, and forestry. Diseases like malaria, dengue fever and cholera are predicted to increase due to changes in water conditions. Ghana signed the Paris Agreement in 2016. It aims to avoid 64 million metric tons of greenhouse gas emissions by 2030, compared to a business-as-usual scenario for 2020–2030. Ghana has committed to net zero by 2060.
There are many forms in which herbs can be administered, the most common of which is a liquid consumed as a herbal tea or a (possibly diluted) plant extract. Herbal teas, or tisanes, are the resultant liquid of extracting herbs into water, though they are made in a few different ways. Infusions are hot water extracts of herbs, such as chamomile or mint, through steeping. Decoctions are the long-term boiled extracts, usually of harder substances like roots or bark. Maceration is the cold infusion of plants with high mucilage-content, such as sage or thyme. To make macerates, plants are chopped and added to cold water. They are left to stand for 7 to 12 hours (depending on the herb used). For most macerates, 10 hours is used. Tinctures are alcoholic extracts of herbs, which are generally stronger than herbal teas. Tinctures are usually obtained by combining pure ethanol (or a mixture of pure ethanol with water) with the herb. A completed tincture has an ethanol percentage of at least 25% (sometimes up to 90%). Non-alcoholic tinctures can be made with glycerin, but it is believed to be less absorbed by the body than alcohol based tinctures and has a shorter shelf life. Herbal wine and elixirs are alcoholic extracts of herbs, usually with an ethanol percentage of 12–38%. Extracts include liquid extracts, dry extracts, and nebulisates. Liquid extracts are liquids with a lower ethanol percentage than tinctures. They are usually made by vacuum distilling tinctures. Dry extracts are extracts of plant material that are evaporated into a dry mass.
The J. Lyons & Co. papers are now stored in the London Metropolitan Archives. The niece and nephew of the Gluckstein brothers were Gluck, a painter; and Louis Gluckstein, a Conservative politician. A descendant of the Salmon side of the original partnership is Nigella Lawson.
Sources: en.wikipedia.org
Such a model is described in the figure on the right and involves the utilization of a master equation that includes all steps of amyloid fibril formation, i.e. primary nucleation, fibril elongation, secondary nucleation and fibril fragmentation. The rate constants of the various steps can be determined from a global fit of a number of time courses of aggregation (for example ThT fluorescence emission versus time) recorded at different protein concentrations. The general master equation approach to amyloid fibril formation with secondary pathways has been developed by Knowles, Vendruscolo, Cohen, Michaels and coworkers and considers the time evolution of the concentration
In inhibitory synapses, the opening of either Cl- or K+ channels diminish the probability of depolarization in postsynaptic neurons and the initiation of an action potential. Astrocytes also exchange information with the synaptic neurons, responding to synaptic activity and, in turn, regulating neurotransmission.
Worried that he was losing touch with medical and nutritional advances, he asked to be transferred to the navy, where he thought he would have more time available for reading and research. The army was reluctant to let him go, but agreed, since he was still a civilian surgeon. He spent a busy three months in the naval hospital at Chatham, studying hard while practicing medicine in the wards, before being posted to HMS Furious. On board ship his medical duties were light, enabling him to do a great deal of reading. He was later recalled to work studying food requirements of the army.
=== Silver Medal at 1948 Summer Olympics === Yugoslavia began their football campaign by defeating Luxembourg 6–1, with five different players scoring the goals. In the quarter-finals and the semi-finals, they would take out Turkey and Great Britain by the same score of 3–1. In the final though, they would lose to Sweden.
1950s: Chinese-American medical scientist Tsai-Fan Yu co-founded a clinic at Mount Sinai Medical Center for the study and treatment of gout. Working with Alexander B. Gutman, Yu established that levels of uric acid were a factor in the pain experienced by gout patients, and subsequently developed multiple effective drugs for the treatment of gout. 1950: Chinese-American particle physicist Chien-Shiung Wu proved the validity of Quantum entanglement which counters Albert Einstein's EPR Paradox and published her work on the new year of the new decade. She also proved the validity of beta decay around this time. 1950: Ghanaian physician and science educator Matilda J. Clerk became the first woman in Ghana and West Africa to attend graduate school, earning a postgraduate diploma at the London School of Hygiene & Tropical Medicine. 1950: Isabella Abbott became the first Native Hawaiian woman to receive a PhD in any science; hers was in botany. 1950: American microbiologist Esther Lederberg became the first to isolate lambda bacteriophage, a DNA virus, from Escherichia coli K-12. 1951: American oncologist Jane C. Wright was the first to identify methotrexate, one of the foundational chemotherapy drugs, as an effective tool against cancerous tumors. 1951: Ghana's Esther Afua Ocloo became the first person of African ancestry to obtain a cooking diploma from the Good Housekeeping Institute in London and to take the post-graduate Food Preservation Course at Long Ashton Research Station, Department of Horticulture, Bristol University.
Sources: en.wikipedia.org
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.
The lyophilized powder is kept refrigerated at 2 to 8 degrees Celsius and protected from light. Reconstituted solutions should be used promptly. Freezing and thawing repeatedly is avoided.